LG Chem, Ltd.

051915.KS·KSE·Basic Materials
Compare
108,800.00−500.00 (−0.46%)today
At close: Nov 5, 3:30 PM KST · May be delayed up to 20 min · KRW

Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close109,300.00
Open109,500.00
Day range105,800.00112,800.00
52-week range100,000.00210,000.00
Off day high−3.55%
Off 52-week high−48.19%
Volume23.75K
Avg. volume (3M)21.77K
Market cap8.52T
EPS (TTM)—
Forward P/E—
P/E ratio (TTM)—
Dividend yield1.88% (2,050.00)
Beta (5Y)1.50
Shares outstanding7.68M
Short interest—
Earnings dateJul 23, 2025
Analyst target—
Profit margin−3.16%

Against its peers

Compare in full ›
051915.KS 011170.KS 298000.KS 1326.TW 4272.T 4114.T
Market cap 8.52T 2.13T 131.12B 380.19B 278.40B 372.25B
P/E (TTM) — — — 27.5 11.1 16.5
Forward P/E — — — 19.8 19.2 25.8
Price/book — — — 0.7 1.0 0.9
Dividend yield 1.88% 2.03% — 0.87% 3.54% 5.58%
1-year change −41.49% −29.61% −3.60% +148.92% +38.94% +42.68%
Today −0.46% +2.44% −7.20% −6.07% −0.41% +0.40%

The closest companies by business and industry (Chemicals). Prices may be delayed up to 20 min.

Seoul Economic Daily··3 outletsPositive

LG Chem Expands Rare Obesity Drug Deal to 1.15 Trillion Won

LG Chem expanded its bivamelagon licensing deal with Rhythm Pharmaceuticals to 1.15 trillion won, with record upfront payments of about 600 billion won. LG Chem (051910) has expanded the value of its licensing deal with U.S.-based Rhythm…

More from 2 other outlets
Seoul Economic Daily··4 outletsPositive

LG Chem Expands Obesity Drug Licensing Deal to $855 Million

Deal Value Grows From $305 Million to $855 Million Company to Receive $350 Million in Additional Upfront Payments Through 2029 Positive Phase 2 Results Clear Path to Phase 3 This Year LG Chem (051910.KS) has expanded the global licensing…

More from 3 other outlets

From the 4Search news index, newest first.

In the news

27mentions in 30 days
27with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 27 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance